Vanguard Capital Management
RXST icon

Vanguard Capital Management’s RxSight RXST Stock Holding History

Vanguard Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.08M Sell
1,675,582
-17,353
-1% -$105K ﹤0.01% 2938
2026
Q1 		$10.4M Buy
+1,692,935
New +$14.1M ﹤0.01% 2711

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management's RXST Position: Q2 2026 in Review

Vanguard Capital Management reduced its RxSight (RXST) stake by 1% in Q2 2026, selling an estimated $105K and leaving 1,675,582 shares worth $8.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

Vanguard Capital Management first reported a position in RXST in Q1 2026 and has held it in 2 quarters since. The position peaked at $10.4M in Q1 2026. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Vanguard Capital Management held 1,675,582 shares of RxSight worth $8.08M as of Q2 2026.
  • Vanguard Capital Management sold 17,353 RxSight shares in Q2 2026, an estimated $105K.
  • RxSight made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2938 holding.
  • Vanguard Capital Management first reported a position in RxSight in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's RxSight position peaked at $10.4M in Q1 2026.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.